Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Bipolar Ventricular Tachycardia (VT) Study
Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Bipolar Ventricular Tachycardia (VT) Study
Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Bipolar Ventricular Tachycardia (VT) Study
Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Bipolar Ventricular Tachycardia (VT) Study
Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Status: Enrolling
Updated:  12/31/1969
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Status: Enrolling
Updated:  12/31/1969
Radiology Imaging Associates
mi
from
Englewood, CO
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Status: Enrolling
Updated: 12/31/1969
Radiology Imaging Associates
mi
from
Englewood, CO
Click here to add this to my saved trials
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Status: Enrolling
Updated:  12/31/1969
Brigham's & Women Hospital
mi
from
Boston, MA
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study
Status: Enrolling
Updated: 12/31/1969
Brigham's & Women Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage
Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage
Status: Enrolling
Updated:  12/31/1969
Loma Linda University
mi
from
Loma Linda, CA
Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage
Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Loma Linda University
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Status: Enrolling
Updated:  12/31/1969
VA North Texas Health Care System
mi
from
Dallas, TX
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Status: Enrolling
Updated: 12/31/1969
VA North Texas Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated:  12/31/1969
Octapharma Research Site
mi
from
Birmingham, AL
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octapharma Research Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated:  12/31/1969
Octapharma Research Site
mi
from
Minneapolis, MN
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octapharma Research Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated:  12/31/1969
Octapharma Research Site
mi
from
Saint Louis, MO
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octapharma Research Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated:  12/31/1969
Octapharma Research Site
mi
from
Atlanta, GA
Octaplas Pediatric Plasma Replacement Trial
An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.
Status: Enrolling
Updated: 12/31/1969
Octapharma Research Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Brandon, FL
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jonesboro, GA
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jonesboro, GA
Click here to add this to my saved trials
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated:  12/31/1969
mi
from
Leuven,
Cancer Venous Thromboembolism (VTE)
A Phase 3b, Prospective, Randomized, Open-label, Blind Evaluator (PROBE) Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated With Cancer
Status: Enrolling
Updated: 12/31/1969
mi
from
Leuven,
Click here to add this to my saved trials
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants - Bakersfield
mi
from
Bakersfield, CA
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants - Bakersfield
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants - Santa Barbara Office
mi
from
Santa Barbara, CA
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants - Santa Barbara Office
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Specialists of Texas
mi
from
Austin, TX
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Specialists of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
York Hospital
mi
from
York, PA
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Heart and Vascualr Institute
mi
from
Elk Grove Village, IL
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Heart and Vascualr Institute
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
An Assessment of the Glider Balloon in Complex Lesions
An Assessment of the Glider Balloon in Complex Lesions
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
A Phase 2a Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
A Phase 2a Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Enoxaparin Metabolism in Reconstructive Surgery Patients
Enoxaparin Metabolism in Reconstructive Surgery Patients
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Enoxaparin Metabolism in Reconstructive Surgery Patients
Enoxaparin Metabolism in Reconstructive Surgery Patients
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
Open-label, Single-dose, Randomized, Two-way (Two-period) Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80mg) Administered Intravenously in Subjects With Chronic Heart Failure
Status: Enrolling
Updated:  12/31/1969
Avail Clinical Research
mi
from
DeLand, FL
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
Open-label, Single-dose, Randomized, Two-way (Two-period) Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80mg) Administered Intravenously in Subjects With Chronic Heart Failure
Status: Enrolling
Updated: 12/31/1969
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Piedmont Healthcare
mi
from
Atlanta, GA
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Piedmont Healthcare
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Advocate Health and Hospitals Corp.
mi
from
Oakbrook Terrace, IL
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Advocate Health and Hospitals Corp.
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Saint Lukes Hospital
mi
from
Kansas City, MO
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Saint Lukes Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
PeaceHealth Sacred Heart Medical Center
mi
from
Springfield, OR
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
PeaceHealth Sacred Heart Medical Center
mi
from
Springfield, OR
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated:  12/31/1969
York Hospital
mi
from
York, PA
The Asahi Intecc PTCA Chronic Total Occlusion Study
The Asahi Intecc PTCA Chronic Total Occlusion Study
Status: Enrolling
Updated: 12/31/1969
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
San Diego Medical Center
mi
from
San Diego, CA
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
MedStar Heart & Vascular Institute
mi
from
Washington,
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
MedStar Heart & Vascular Institute
mi
from
Washington,
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Maine Medical Center
mi
from
Portland, ME
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health Sysem
mi
from
Ann Arbor, MI
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health Sysem
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Long Island Jewish Northshore University Hospital
mi
from
New Hyde Park, NY
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Long Island Jewish Northshore University Hospital
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
The Chirst Hospital
mi
from
Cincinnati, OH
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
The Chirst Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Harrisburg Hospital
mi
from
Harrisburg, PA
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Harrisburg Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Erlanger Medical Center
mi
from
Chattanooga, TN
Endurant Evo US Clinical Trial
Endurant Evo US Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Erlanger Medical Center
mi
from
Chattanooga, TN
Click here to add this to my saved trials